Literature DB >> 26921428

Isolation and Structural Elucidation of Brevibacillin, an Antimicrobial Lipopeptide from Brevibacillus laterosporus That Combats Drug-Resistant Gram-Positive Bacteria.

Xu Yang1, En Huang1, Chunhua Yuan2, Liwen Zhang3, Ahmed E Yousef4,5.   

Abstract

A new environmental bacterial strain exhibited strong antimicrobial characteristics against methicillin-resistant Staphylococcus aureus, vancomycin-resistant strains of Enterococcus faecalis and Lactobacillus plantarum, and other Gram-positive bacteria. The producer strain, designated OSY-I1, was determined to be Brevibacillus laterosporusvia morphological, biochemical, and genetic analyses. The antimicrobial agent was extracted from cells of OSY-I1 with isopropanol, purified by high-performance liquid chromatography, and structurally analyzed using mass spectrometry (MS) and nuclear magnetic resonance (NMR). The MS and NMR results, taken together, uncovered a linear lipopeptide consisting of 13 amino acids and an N-terminal C6 fatty acid (FA) chain, 2-hydroxy-3-methylpentanoic acid. The lipopeptide (FA-Dhb-Leu-Orn-Ile-Ile-Val-Lys-Val-Val-Lys-Tyr-Leu-valinol, where Dhb is α,β-didehydrobutyric acid and valinol is 2-amino-3-methyl-1-butanol) has a molecular mass of 1,583.0794 Da and contains three modified amino acid residues: α,β-didehydrobutyric acid, ornithine, and valinol. The compound, designated brevibacillin, was determined to be a member of a cationic lipopeptide antibiotic family. In addition to its potency against drug-resistant bacteria, brevibacillin also exhibited low MICs (1 to 8 μg/ml) against selected foodborne pathogenic and spoilage bacteria, such as Listeria monocytogenes,Bacillus cereus, and Alicyclobacillus acidoterrestris Purified brevibacillin showed no sign of degradation when it was held at 80 °C for 60 min, and it retained at least 50% of its antimicrobial activity when it was held for 22 h under acidic or alkaline conditions. On the basis of these findings, brevibacillin is a potent antimicrobial lipopeptide which is potentially useful to combat drug-resistant bacterial pathogens and foodborne pathogenic and spoilage bacteria.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26921428      PMCID: PMC4836408          DOI: 10.1128/AEM.00315-16

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  29 in total

Review 1.  Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.

Authors:  M E Evans; D J Feola; R P Rapp
Journal:  Ann Pharmacother       Date:  1999-09       Impact factor: 3.154

2.  Bogorol A produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics.

Authors:  T Barsby; M T Kelly; S M Gagné; R J Andersen
Journal:  Org Lett       Date:  2001-02-08       Impact factor: 6.005

Review 3.  From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides.

Authors:  Y Shai; Z Oren
Journal:  Peptides       Date:  2001-10       Impact factor: 3.750

Review 4.  Molecular diversity in gene-encoded, cationic antimicrobial polypeptides.

Authors:  A Tossi; L Sandri
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

5.  Purification and characterization of a novel antimicrobial peptide from Brevibacillus laterosporus strain A60.

Authors:  Jing Zhao; Lihua Guo; Hongmei Zeng; Xiufen Yang; Jingjing Yuan; Huaixing Shi; Yehui Xiong; Mingjia Chen; Lei Han; Dewen Qiu
Journal:  Peptides       Date:  2012-01-08       Impact factor: 3.750

6.  Ultrashort antibacterial and antifungal lipopeptides.

Authors:  Arik Makovitzki; Dorit Avrahami; Yechiel Shai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

Review 7.  A framework for global surveillance of antibiotic resistance.

Authors:  Hajo Grundmann; Keith P Klugman; Timothy Walsh; Pilar Ramon-Pardo; Betuel Sigauque; Wasif Khan; Ramanan Laxminarayan; Andreas Heddini; John Stelling
Journal:  Drug Resist Updat       Date:  2011-04-08       Impact factor: 18.500

8.  The lipopeptide antibiotic paenibacterin binds to the bacterial outer membrane and exerts bactericidal activity through cytoplasmic membrane damage.

Authors:  En Huang; Ahmed E Yousef
Journal:  Appl Environ Microbiol       Date:  2014-02-21       Impact factor: 4.792

9.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

10.  Structure and biosynthesis of the BT peptide antibiotic from Brevibacillus texasporus.

Authors:  Xiaofeng Wu; Johnathan Ballard; Yi Wei Jiang
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

View more
  17 in total

Review 1.  Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review.

Authors:  Xu Yang; Ahmed E Yousef
Journal:  World J Microbiol Biotechnol       Date:  2018-03-29       Impact factor: 3.312

2.  Simultaneous Production of Antibacterial Protein and Lipopeptides in Bacillus tequilensis, Detected by MALDI-TOF and GC Mass Analyses.

Authors:  Fatemeh S Ghoreishi; Rasoul Roghanian; Giti Emtiazi
Journal:  Probiotics Antimicrob Proteins       Date:  2022-01-16       Impact factor: 4.609

3.  Identification and Characterization of a Potential Antimicrobial Peptide Isolated from Soil Brevibacillus sp. WUL10 and Its Activity against MRSA Pathogens.

Authors:  Apichart Atipairin; Nuttapon Songnaka; Sucheewin Krobthong; Yodying Yingchutrakul; Thapanee Chinnawong; Thamonwan Wanganuttara
Journal:  Trop Med Infect Dis       Date:  2022-06-07

4.  Novel Modifications of Nonribosomal Peptides from Brevibacillus laterosporus MG64 and Investigation of Their Mode of Action.

Authors:  Zhibo Li; Reinder H de Vries; Parichita Chakraborty; Chunxu Song; Xinghong Zhao; Dirk-Jan Scheffers; Gerard Roelfes; Oscar P Kuipers
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

5.  Brevibacillus laterosporus isolated from the digestive tract of honeybees has high antimicrobial activity and promotes growth and productivity of honeybee's colonies.

Authors:  Jamal M Khaled; Fahd A Al-Mekhlafi; Ramzi A Mothana; Naiyf S Alharbi; Khalid E Alzaharni; Anwar H Sharafaddin; Shine Kadaikunnan; Ahmed S Alobaidi; Noofal I Bayaqoob; Marimuthu Govindarajan; Giovanni Benelli
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-09       Impact factor: 4.223

6.  The determination of antibacterial mode for cationic lipopeptides brevibacillins against Salmonella typhimurium by quantum chemistry calculation.

Authors:  Yubo Wu; Ting Nie; Fanqiang Meng; Libang Zhou; Meirong Chen; Jing Sun; Zhaoxin Lu; Yingjian Lu
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-23       Impact factor: 4.813

7.  Novel linear lipopeptide paenipeptin C' binds to lipopolysaccharides and lipoteichoic acid and exerts bactericidal activity by the disruption of cytoplasmic membrane.

Authors:  Sun Hee Moon; En Huang
Journal:  BMC Microbiol       Date:  2019-01-08       Impact factor: 3.605

8.  Brevibacillus laterosporus strains BGSP7, BGSP9 and BGSP11 isolated from silage produce broad spectrum multi-antimicrobials.

Authors:  Marija Miljkovic; Sofija Jovanovic; Paula M O'Connor; Nemanja Mirkovic; Branko Jovcic; Brankica Filipic; Miroslav Dinic; David John Studholme; Djordje Fira; Paul D Cotter; Milan Kojic
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

9.  Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity.

Authors:  Xinghong Zhao; Xiaoqi Wang; Rhythm Shukla; Raj Kumar; Markus Weingarth; Eefjan Breukink; Oscar P Kuipers
Journal:  Front Microbiol       Date:  2021-06-17       Impact factor: 5.640

10.  Draft Genome Sequence of Brevibacillus laterosporus OSY-I1, a Strain That Produces Brevibacillin, Which Combats Drug-Resistant Gram-Positive Bacteria.

Authors:  Xu Yang; En Huang; Mustafa Yesil; Lingzi Xiaoli; Edward G Dudley; Ahmed E Yousef
Journal:  Genome Announc       Date:  2017-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.